Patellofemoral Pain Syndrome
0
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Ferring PharmaceuticalsArgentina - Buenos Aires
1 programIntra-Articular Hyaluronic Acid-EuflexxaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Plus TherapeuticsPENS
Articulate LabsKneeStim
Ferring PharmaceuticalsIntra-Articular Hyaluronic Acid-Euflexxa
Clinical Trials (3)
Total enrollment: 50 patients across 3 trials
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
Start: Mar 2015Est. completion: Dec 2017
N/ACompleted
Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain
Start: Sep 2014Est. completion: Mar 201720 patients
N/ACompleted
Effectiveness Trial for Evaluating IAHA for PFPS
Start: Apr 2013Est. completion: Mar 201730 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.